tirzepatide self pay price Eli Lilly has launched new self-pay options for tirzepatide, introducing 7.5 mg and 10 mg single-dose vials for $499 through the Zepbound Journey Program. This initiative, available exclusively via LillyDirect Lilly launches lower-price weight-loss drug
Description
Both equal 0.5 mL on a U-100 syringe
Branded Zepbound and LillyDirect self-pay vials remain fully legal, and using them to self-administer a sub-2.5 mg dose under physician supervision is legal
Funciona de manera increble
The unit readings are clean, round numbers that are easy to identify on the syringe barrel
The solution is clear, not pink
